Ftse Mib
33.308,77
-1,09%
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
NASDAQ
17.689,36
-0,18%
Bitcoin
64.086,97
-0,25%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Phoenix Biotech Aquisition Corporation (PBAXU) Phoenix Biotech Aquisition Corporation (PBAXU) Notizie

PBAXU

Phoenix Biotech Aquisition (PBAXU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PBAXU
DataOraFonteTitoloSimboloCompagnia
05/06/202423:13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
22/05/202414:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/05/202423:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
16/05/202412:28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
06/05/202423:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/05/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/05/202406:16Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
01/05/202422:45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
15/04/202422:36Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/04/202423:27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202413:12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202413:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202403:54Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/03/202402:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
27/02/202403:37Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
23/02/202423:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
20/02/202423:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202401:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202418:14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
22/01/202423:29Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
19/07/202314:33Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/07/202319:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
07/06/202312:05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
05/06/202315:27Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
12/05/202322:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
24/03/202311:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202321:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202312:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
20/12/202222:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
21/11/202214:39Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PBAXU

La tua Cronologia

TG
C5X
Crew Energy
LSE
61RV
Barclays 30
UNSW3
IQETH
Everipedia IQ
NASDAQ
FOZBGX
Automated Quantitative A...
NASDAQ
FLEX
Flex
NYSE
UDR-G.CL
BIT
P1SZT0
NLBNPIT1SZT0 20241220 22
TG
A0D2GT
Generalitat de Catalunya
BIT
NSCIT5370910
EBRD
USOTC
EMPO
Empowered Products (CE)
LSE
LBE
Longboat Energy
NASDAQ
MNTV
Momentive Global
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network